{"success":true,"data":{"pressRelease":{"id":"160058","rtpr_id":"nPre4t3Z1a-20261005","ticker":"ZZB","exchange":"Nasdaq Stockholm","all_tickers":["ZZB"],"title":"ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2026","author":"PR Newswire","published_at":"2026-10-05T07:36:44.210Z","article_body":"ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2026\nPR Newswire\n\nGOTHENBURG, Sweden, Oct. 5, 2026\n\nZinzino group revenue increased 18 % in Q3, compared with the previous year.\n\nGOTHENBURG, Sweden, Oct. 5, 2026 /PRNewswire/ -- The revenue in September\nfor Zinzino's sales markets increased by 15% and amounted to SEK 310.9\n(270.8) million. Faun Pharma's external sales increased and amounted to SEK\n6.4 (3.7) million. Overall, the Group increased revenues by 16% to SEK 317.3\n(274.5) million compared with the previous year.\n\nRevenue in Zinzino's sales markets increased by 18% in the third quarter of\n2026 compared with the same period last year and amounted to SEK 917.3 (774.8)\nmillion. Total revenues in the Group increased by 18% in the third quarter and\namounted to SEK 928.2 (784.1) million.\n\nAccumulated revenue for January – September 2026 increased by 21% to SEK\n2,787.1 (2,302.2) million.\n\nRevenues were distributed as follows:\n\n Regions, mSEK        26-Sep  25-Sep  Change  Q3 2026  Q3 2025  Change  YTD 2026  YTD 2025  Change  \n The Nordics          26.6    25.5    5 %     76.1     78.7     -3 %    233.8     234.1     0 %     \n Central Europe       102.9   93.4    10 %    288.8    242.4    19 %    846.5     657.5     29 %    \n East Europe          25.5    29.3    -13 %   76.7     89.6     -14 %   243.0     276.0     -12 %   \n South & West Europe  48.9    48.9    0 %     144.1    136.0    6 %     451.4     398.0     13 %    \n The Baltics          8.2     8.8     -7 %    24.8     28.5     -13 %   81.3      85.2      -5 %    \n North America        62.2    39.8    56 %    195.     126.1    55 %    596.4     373.7     60 %    \n South America        3.6     1.3     177 %   10.1     3.5      189 %   32.8      8.2       300 %   \n Asia-Pacific         30.9    22.0    40 %    95.1     64.2     48 %    237.2     213.2     11 %    \n Africa               2.1     1.9     11 %    6.5      5.8      12 %    18.8      16.0      18 %    \n Zinzino              310.9   270.8   15 %    917.3    774.8    18 %    2,741.2   2,261.9   21 %    \n Faun Pharma          6.4     3.7     73 %    10.9     9.3      17 %    45.9      40.3      14 %    \n Zinzino Group        317.3   274.5   16 %    928.2    784.1    18 %    2,787.1   2,302.2   21 %    \n\nCountries in regions:\n-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden \n-Central Europe: Austria, Germany, Switzerland\n-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania \n-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta,\nNetherlands, Slovenia, Portugal, Spain, United Kingdom, Belgium, Ireland,\nSerbia, Turkey, Canary Islands\n-The Baltics: Estonia, Latvia, Lithuania\n-North America: Canada, USA, Mexico\n-South America: Peru, Colombia\n-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore,\nTaiwan, Thailand, China, Philippines, South Korea\n-Africa: South Africa\n\nFor more information:\nDag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com\nFredrik Nielsen CFO Zinzino +46 707 900 174, fredrik.nielsen@zinzino.com\n\nPictures for publication free of charge: marketing@zinzino.com\n\nCertified Adviser: Carnegie Investment Bank AB (publ)\n\nThis information was brought to you by Cision http://news.cision.com\n\nhttps://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-q3-2026,c4404120\n\nThe following files are available for download:\n\n https://mb.cision.com/Public/10976/4404120/9f56a6e68acf6fe3.pdf  2609 Press release Sales report EN  \n\nView original\ncontent:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-q3-2026-302898203.html\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPre4t3Z1a-20261005","title":"ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2026","author":"PR Newswire","ticker":"ZZB","created":"2026-10-05T07:36:44.210Z","tickers":["ZZB"],"exchange":"Nasdaq Stockholm","article_body":"ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2026\nPR Newswire\n\nGOTHENBURG, Sweden, Oct. 5, 2026\n\nZinzino group revenue increased 18 % in Q3, compared with the previous year.\n\nGOTHENBURG, Sweden, Oct. 5, 2026 /PRNewswire/ -- The revenue in September\nfor Zinzino's sales markets increased by 15% and amounted to SEK 310.9\n(270.8) million. Faun Pharma's external sales increased and amounted to SEK\n6.4 (3.7) million. Overall, the Group increased revenues by 16% to SEK 317.3\n(274.5) million compared with the previous year.\n\nRevenue in Zinzino's sales markets increased by 18% in the third quarter of\n2026 compared with the same period last year and amounted to SEK 917.3 (774.8)\nmillion. Total revenues in the Group increased by 18% in the third quarter and\namounted to SEK 928.2 (784.1) million.\n\nAccumulated revenue for January – September 2026 increased by 21% to SEK\n2,787.1 (2,302.2) million.\n\nRevenues were distributed as follows:\n\n Regions, mSEK        26-Sep  25-Sep  Change  Q3 2026  Q3 2025  Change  YTD 2026  YTD 2025  Change  \n The Nordics          26.6    25.5    5 %     76.1     78.7     -3 %    233.8     234.1     0 %     \n Central Europe       102.9   93.4    10 %    288.8    242.4    19 %    846.5     657.5     29 %    \n East Europe          25.5    29.3    -13 %   76.7     89.6     -14 %   243.0     276.0     -12 %   \n South & West Europe  48.9    48.9    0 %     144.1    136.0    6 %     451.4     398.0     13 %    \n The Baltics          8.2     8.8     -7 %    24.8     28.5     -13 %   81.3      85.2      -5 %    \n North America        62.2    39.8    56 %    195.     126.1    55 %    596.4     373.7     60 %    \n South America        3.6     1.3     177 %   10.1     3.5      189 %   32.8      8.2       300 %   \n Asia-Pacific         30.9    22.0    40 %    95.1     64.2     48 %    237.2     213.2     11 %    \n Africa               2.1     1.9     11 %    6.5      5.8      12 %    18.8      16.0      18 %    \n Zinzino              310.9   270.8   15 %    917.3    774.8    18 %    2,741.2   2,261.9   21 %    \n Faun Pharma          6.4     3.7     73 %    10.9     9.3      17 %    45.9      40.3      14 %    \n Zinzino Group        317.3   274.5   16 %    928.2    784.1    18 %    2,787.1   2,302.2   21 %    \n\nCountries in regions:\n-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden \n-Central Europe: Austria, Germany, Switzerland\n-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania \n-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta,\nNetherlands, Slovenia, Portugal, Spain, United Kingdom, Belgium, Ireland,\nSerbia, Turkey, Canary Islands\n-The Baltics: Estonia, Latvia, Lithuania\n-North America: Canada, USA, Mexico\n-South America: Peru, Colombia\n-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore,\nTaiwan, Thailand, China, Philippines, South Korea\n-Africa: South Africa\n\nFor more information:\nDag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com\nFredrik Nielsen CFO Zinzino +46 707 900 174, fredrik.nielsen@zinzino.com\n\nPictures for publication free of charge: marketing@zinzino.com\n\nCertified Adviser: Carnegie Investment Bank AB (publ)\n\nThis information was brought to you by Cision http://news.cision.com\n\nhttps://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-q3-2026,c4404120\n\nThe following files are available for download:\n\n https://mb.cision.com/Public/10976/4404120/9f56a6e68acf6fe3.pdf  2609 Press release Sales report EN  \n\nView original\ncontent:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-q3-2026-302898203.html\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-05T07:36:44.247562604Z","server_sent_at_ms":1791185804247},"received_at":"2026-10-05T07:36:44.299Z","source_url":null},"analysis":{"id":"148635","press_release_id":"160058","analysis_json":{"industry":{"label":"Personal Care Products","sector":"Consumer Staples"},"redFlags":["revenue-only preliminary report with no profit, margin, or EPS data","East Europe revenue down 14% and Baltics down 13% in Q3"],"eventType":"earnings","narrative":"Zinzino reported preliminary Q3 2026 group revenue of SEK 928.2 million, up 18% year-over-year, with sales-market revenue of SEK 917.3 million also up 18%.\n\nGrowth was led by North America (+55%) and South America (+189%), while East Europe (-14%) and the Baltics (-13%) declined. YTD revenue through September rose 21% to SEK 2,787.1 million.\n\nThe release is revenue-only preliminary data with no profitability metrics; subsidiary Faun Pharma's external sales grew 17% in the quarter.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"Zinzino's 18% Q3 revenue growth driven by North America surge while East Europe contracts."},"keyFigures":{"revenue":928200000,"revenueYoy":"18%","customDimensions":{"currency":"SEK","ytd_growth":"21%","september_growth":"16%","north_america_q3_growth":"55%","south_america_q3_growth":"189%","q3_prior_year_revenue_msek":784.1,"faun_pharma_q3_revenue_msek":10.9,"q3_sales_market_revenue_msek":917.3,"september_group_revenue_msek":317.3}},"namedEntities":{"people":[{"name":"Dag Bergheim Pettersen","role":"CEO"},{"name":"Fredrik Nielsen","role":"CFO"}],"products":[],"companies":[{"name":"Zinzino AB (publ)","ticker":"ZZB","relationship":"filer"},{"name":"Faun Pharma","relationship":"subsidiary"},{"name":"Carnegie Investment Bank AB","relationship":"certified adviser"}],"dollarAmounts":[{"amount":"SEK 928.2 million","context":"Q3 2026 group revenue"},{"amount":"SEK 917.3 million","context":"Q3 2026 sales-market revenue"},{"amount":"SEK 2,787.1 million","context":"YTD Jan-Sep 2026 group revenue"},{"amount":"SEK 317.3 million","context":"September 2026 group revenue"}]},"materialImpact":{"score":3,"reasoning":"Preliminary Q3 sales report shows 18% group revenue growth with strong North America (+55%) and South America (+189%) momentum, though it is revenue-only with no profit data and some regions declined (East Europe -14%, Baltics -13%)."},"tickerRelevance":{"others":[],"primary":"ZZB"},"globalImportance":30,"audienceRelevance":20,"eventTypeSecondary":["operations_update"],"importanceComponents":{"growthRate":"18% Q3 / 21% YTD","tickerTier":"small-cap","eventGravity":"preliminary-sales-report","issuerAuthored":true}},"event_type":"earnings","event_type_secondary":["operations_update"],"sentiment":"bullish","material_impact_score":3,"narrative":"Zinzino reported preliminary Q3 2026 group revenue of SEK 928.2 million, up 18% year-over-year, with sales-market revenue of SEK 917.3 million also up 18%.\n\nGrowth was led by North America (+55%) and South America (+189%), while East Europe (-14%) and the Baltics (-13%) declined. YTD revenue through September rose 21% to SEK 2,787.1 million.\n\nThe release is revenue-only preliminary data with no profitability metrics; subsidiary Faun Pharma's external sales grew 17% in the quarter.","key_figures":{"revenue":928200000,"revenueYoy":"18%","customDimensions":{"currency":"SEK","ytd_growth":"21%","september_growth":"16%","north_america_q3_growth":"55%","south_america_q3_growth":"189%","q3_prior_year_revenue_msek":784.1,"faun_pharma_q3_revenue_msek":10.9,"q3_sales_market_revenue_msek":917.3,"september_group_revenue_msek":317.3}},"named_entities":{"people":[{"name":"Dag Bergheim Pettersen","role":"CEO"},{"name":"Fredrik Nielsen","role":"CFO"}],"products":[],"companies":[{"name":"Zinzino AB (publ)","ticker":"ZZB","relationship":"filer"},{"name":"Faun Pharma","relationship":"subsidiary"},{"name":"Carnegie Investment Bank AB","relationship":"certified adviser"}],"dollarAmounts":[{"amount":"SEK 928.2 million","context":"Q3 2026 group revenue"},{"amount":"SEK 917.3 million","context":"Q3 2026 sales-market revenue"},{"amount":"SEK 2,787.1 million","context":"YTD Jan-Sep 2026 group revenue"},{"amount":"SEK 317.3 million","context":"September 2026 group revenue"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-05T07:36:51.212Z","global_importance":30,"audience_relevance":20,"importance_components":{"growthRate":"18% Q3 / 21% YTD","tickerTier":"small-cap","eventGravity":"preliminary-sales-report","issuerAuthored":true}},"durationMs":6907,"modelName":"glm-5.3-flashx"}}